An Evidence-Based Approach to the Use of Predictive Biomarkers in the Treatment of Non- Small Cell Lung Cancer (NSCLC)

por Quinton, Cindy, Ellis, Peter M.
Publicado 2011

Challenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare System

por Dawe, David E., Ellis, Peter M.
Publicado 2012

Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease

por Sathiyapalan, Arani, Baloush, Ziad, Ellis, Peter M.
Publicado 2023

Patterns of Relapse in Small Cell Lung Cancer: Competing Risks of Thoracic versus CNS Relapse

por Ellis, Peter M., Swaminath, Anand, Pond, Gregory R.
Publicado 2021

Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis

por Sathiyapalan, Arani, Febbraro, Michela, Pond, Gregory R., Ellis, Peter M.
Publicado 2022

Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer

por Kavsak, Peter A., Hoard, Brock, Mackett, Katharine, Mukherjee, Som D., Bordeleau, Louise, Ellis, Peter M., Dhesy-Thind, Sukhbinder
Publicado 2023

Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab

por Zhou, Shijie, Cirne, Filipe, Chow, Justin, Zereshkian, Arman, Bordeleau, Louise, Dhesy-Thind, Sukhbinder, Ellis, Peter M, Mukherjee, Som D, Aghel, Nazanin, Leong, Darryl P
Publicado 2023

A mixed methods approach to understand variation in lung cancer practice and the role of guidelines

por Brouwers, Melissa C, Makarski, Julie, Garcia, Kimberly, Akram, Saira, Darling, Gail E, Ellis, Peter M, Evans, William K, Giacomini, Mita, Martelli-Reid, Lorraine, Ung, Yee C
Publicado 2014

Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis

por Alhussein, Muhammad Mustafa, Mokbel, Abir, Cosman, Tammy, Aghel, Nazanin, Yang, Eric H., Mukherjee, Som D., Dent, Susan, Ellis, Peter M., Dhesy-Thind, Sukhbinder, Leong, Darryl P.
Publicado 2021

Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: JACC: CardioOncology State-of-the-Art Review

por Leong, Darryl P., Cirne, Filipe, Aghel, Nazanin, Baro Vila, Rocio C., Cavalli, Germano D., Ellis, Peter M., Healey, Jeff S., Whitlock, Richard, Khalaf, Dina, Mian, Hira, Jolly, Sanjit S., Mehta, Shamir R., Dent, Susan
Publicado 2023

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer

por Melosky, Barbara L., Leighl, Natasha B., Dawe, David, Blais, Normand, Wheatley-Price, Paul F., Chu, Quincy S.-C., Juergens, Rosalyn A., Ellis, Peter M., Sun, Alexander, Schellenberg, Devin, Ionescu, Diana N., Cheema, Parneet K.
Publicado 2023

Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity: A Phase I Trial

por Leong, Darryl P., Cosman, Tammy, Alhussein, Muhammad M., Kumar Tyagi, Nidhi, Karampatos, Sarah, Barron, Carly C., Wright, Douglas, Tandon, Vikas, Magloire, Patrick, Joseph, Philip, Conen, David, Devereaux, P.J., Ellis, Peter M., Mukherjee, Som D., Dhesy-Thind, Sukhbinder
Publicado 2019

Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials

por Wells, J Connor, Sidhu, Aven, Ding, Keyue, Smoragiewicz, Martin, Heng, Daniel Y C, Shepherd, Frances A, Ellis, Peter M, Bradbury, Penelope A, Jonker, Derek J, Siu, Lillian L, Gelmon, Karen A, Karapetis, Christos, Shapiro, Jeremy, Nott, Louise, O’Callaghan, Christopher J, Parulekar, Wendy R, Seymour, Lesley, Monzon, Jose G
Publicado 2022

Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients

por Martin, Petra, Shiau, Carolyn J, Pasic, Maria, Tsao, Ming, Kamel-Reid, Suzanne, Lin, Stephanie, Tudor, Roxana, Cheng, Susanna, Higgins, Brian, Burkes, Ronald, Ng, Matilda, Arif, Saroosh, Ellis, Peter M, Hubay, Stacy, Kuruvilla, Sara, Laurie, Scott A, Li, Jing, Hwang, David, Lau, Anthea, Shepherd, Frances A, Le, Lisa W, Leighl, Natasha B
Publicado 2016